Oesophageal varices as an initial manifestation of JAK2-positive myeloproliferative neoplasms

被引：0
|
作者：
Link, C. [1 ]
Platzbecker, U. [1 ]
Brueckner, S. [1 ]
Thiede, C. [1 ]
Ehninger, G. [1 ]
Schuler, M. [1 ]
机构：
[1] Univ Klinikum Dresden, Med Klin 1, Dresden, Germany
来源：
ONKOLOGIE | 2012年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [21] Targeting JAK2 in the therapy of myeloproliferative neoplasms
    Reddy, Mamatha M.
    Deshpande, Anagha
    Sattler, Martin
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (03) : 313 - 324
  • [22] Philadelphia chromosome positive AML arising from JAK2-positive myelofibrosis
    Brattas, Marte Karen
    Lilleeng, Kyrre
    Hovland, Randi
    Laegreid, Ingvild Jenssen
    Vorland, Marta
    Leh, Friedemann
    Bruserud, Oystein
    Gjertsen, Bjorn Tore
    Reikvam, Hakon
    BIOMARKER RESEARCH, 2018, 6
  • [23] New JAK2 inhibitors for myeloproliferative neoplasms
    Quintas-Cardama, Alfonso
    Verstovsek, Srdan
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (07) : 961 - 972
  • [24] JAK2 Mutation and Thrombosis in the Myeloproliferative Neoplasms
    Vannucchi, Alessandro M.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2010, 5 (01) : 22 - 28
  • [25] JAK2 INHIBITORS FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS
    Tefferi, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 20 - 21
  • [26] JAK2 Mutation and Thrombosis in the Myeloproliferative Neoplasms
    Alessandro M. Vannucchi
    Current Hematologic Malignancy Reports, 2010, 5 : 22 - 28
  • [27] Therapy with JAK2 Inhibitors for Myeloproliferative Neoplasms
    Santos, Fabio P. S.
    Verstovsek, Srdan
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2012, 26 (05) : 1083 - +
  • [28] Cutaneous manifestations of JAK2+myeloproliferative neoplasms
    Kentley, J.
    Theodoulou, A.
    Wijesuriya, N.
    Ekeowa-Anderson, A.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2018, 43 (05) : 615 - 616
  • [29] JAK2 in Myeloproliferative Neoplasms: Still a Protagonist
    Bader, Michael Stephan
    Meyer, Sara Christina
    PHARMACEUTICALS, 2022, 15 (02)
  • [30] JAK2 inhibitors and their impact in myeloproliferative neoplasms
    Geyer, Holly L.
    Tibes, Raoul
    Mesa, Ruben A.
    HEMATOLOGY, 2012, 17 : S129 - S132
12345